Doctor's Bag Tasmania: S8 Storage, Drug Register, Section 59E, and DORA Compliance Guide (2026)

This information is published by Doc Pouch Pty Ltd (ABN 28 695 916 306), trading as DocPouch (docpouch.com.au), for AHPRA-registered healthcare professionals practising in Tasmania. It is general regulatory and operational information only and does not constitute legal, regulatory, clinical, or professional advice. No solicitor-client or advisor-client relationship is created by reading or relying on this article. DocPouch makes no warranty as to the currency, accuracy, or completeness of the information; readers must verify all current requirements directly against the Poisons Act 1971 (Tas), the Poisons Regulations 2018 (Tas), and current Tasmanian Department of Health Pharmaceutical Services Branch guidance. Use of this article is at the reader's own risk and on the reader's own professional judgement.

If you carry a PBS Doctor's Bag in Tasmania, the rules that govern S8 (narcotic substance) storage, the drug register, transport, prescribing, and DORA are set by Tasmanian state law, not by the Pharmaceutical Benefits Scheme. Tasmania uses distinctive legislative terminology that practitioners trained interstate often find unfamiliar. Schedule 8 substances are referred to in Tasmanian law as narcotic substances, with Schedule 4 monitored medicines referred to as declared restricted substances or S4Ds. The operative legislation is the Poisons Act 1971 (Tas) (the Poisons Act) and the Poisons Regulations 2018 (the Poisons Regulations). The state-specific authority regime under section 59E of the Poisons Act sets out when an authority from the Secretary of the Department of Health is required to prescribe S8 medicines.

Tasmania was the first Australian state to implement real-time prescription monitoring (DORA, operational since 2009), and the framework continues to feature unique terminology and procedural elements not found in other jurisdictions. From 16 February 2026, significant changes commenced governing interstate prescribing in Tasmania. If you hold a PBS Doctor's Bag and practise in Tasmania, this guide sets out what you actually need to do to remain compliant in 2026.

Which laws govern the doctor's bag in Tasmania?

  • Commonwealth (PBS) law: The National Health (Prescriber Bag Supplies) Determination 2024 governs which items you can order, in what quantities, and from whom. The Commonwealth scheme uses the PB052 Prescriber Bag Supply Order Book.
  • Tasmanian state law: The Poisons Act 1971 and the Poisons Regulations 2018 govern lawful possession, storage, transport, recordkeeping, prescribing, supply, and destruction of S4 and S8 medicines once you hold them. The Tasmanian Department of Health Pharmaceutical Services Branch publishes binding subordinate guidance and operates DORA, the state's real-time prescription monitoring system.

Tasmanian Terminology: Narcotic Substances and Declared Restricted Substances

Tasmania's Poisons Act 1971 uses terminology that differs materially from other states:

  • Narcotic substance: Defined in section 3(1) of the Poisons Act as "a substance that is, for the time being, specified in Schedule 8 to the Poisons List". For practical purposes, this corresponds to Schedule 8 substances under the Commonwealth Poisons Standard.
  • Midwifery narcotic substance: A narcotic substance that is declared by the Minister, by order, to be a midwifery narcotic substance for the purposes of the Act.
  • Restricted substance: Corresponds broadly to Schedule 4 substances, with subsets that may be declared by the Minister.
  • Midwifery restricted substance: A restricted substance declared by the Minister to be a midwifery restricted substance.
  • Declared restricted substances (S4Ds): A subset of Schedule 4 substances subject to additional controls, often referred to in Tasmanian operational documentation as "S4Ds".

Cannabis became a narcotic substance from 1 November 2016, meaning certain cannabis products became S8 medicines for medicinal purposes in Tasmania. Authorisation under section 59E of the Poisons Act is required prior to issuing a prescription for a Schedule 8 medicinal cannabis product to a patient.

Section 59E: The Authority Regime

Section 59E of the Poisons Act 1971 sets out the legal framework for authorising doctors to prescribe S8 medicines including strong opioids, psychostimulants, S8 benzodiazepines, and S8 cannabis. The Secretary of the Department of Health may issue an authority under section 59E, subject to conditions.

For Doctor's Bag holders, the practical position is:

  • The Doctor's Bag itself is for direct administration at the point of care; it is not a workaround for the section 59E authority regime.
  • Where a Doctor's Bag administration is followed by a continuing prescription for an S8 substance, the section 59E authority requirements apply in the usual way.
  • Authority is required prior to issuing a prescription for an S8 medicine in defined circumstances, including for opioids in long-term treatment, psychostimulants for ADHD, S8 benzodiazepines, and S8 medicinal cannabis. Verify the current scope of the authority requirement directly against current Pharmaceutical Services Branch guidance, as the framework has been refined periodically.

Section 59B and 59C: Related Statutory Obligations

  • Section 59B requires notification for drug seeking, misuse, or inappropriate use. The Tasmanian Department of Health publishes a Notification Required for Drug Seeking, Misuse and Inappropriate Use form for compliance.
  • Section 59C creates an offence of making an S8 substance available to a person without proper authority. This is particularly relevant in the interstate prescribing context (see below).

Sections 25A and 25B: Authorisation of Nurses, Midwives, and Nurse Practitioners

Section 25A of the Poisons Act allows the Minister to authorise a registered nurse or midwife in writing to be in possession of and to supply restricted substances or narcotic substances of a class specified in the authorisation, in such circumstances and subject to such conditions as may be specified. Section 25B allows the Secretary to authorise nurse practitioners. These provisions apply to nurse practitioners and authorised midwives who hold PBS Doctor's Bag prescribing rights and who practise in Tasmania.

Formal Review Process for Section 59E Authorities

Tasmania operates a formal review process for s59E authority decisions. This process was implemented following a review by the Tasmanian Ombudsman's Office. A medical practitioner, a patient, or their carer may apply to request a review of a delegate's decision (where conditions have been imposed on an authority or where an application has been refused). Information on the review process and application form is published on the Department of Health website.

Storage of Narcotic Substances

Based on current Tasmanian Department of Health Pharmaceutical Services Branch guidance and the framework set out in the Poisons Act and Poisons Regulations, the operational expectations for storage of narcotic substances are:

  • Locked storage required: Narcotic substances must be stored in a securely locked storage facility that prevents unauthorised access.
  • Doctor's Bag in personal possession: The Doctor's Bag must remain in the practitioner's personal possession during home visits and after-hours work.
  • S8 contents not unattended: The S8 medicines in the bag must not be left unattended outside a compliant locked storage facility.
  • At rest at the surgery: When the bag is at the practitioner's principal place of practice and not in active use, the S8 contents are required to be stored in compliance with the locked storage requirement at the surgery.

Verify the current specific construction or detection requirements directly against the Poisons Regulations 2018 and Pharmaceutical Services Branch guidance, as Tasmania's framework operates with less prescriptive construction detail than Victoria's Reg 74 or Western Australia's MPR 2016 Schedule 3, but with the same operational locked-and-secured principle.

Drug Register Requirements

Based on current Tasmanian Department of Health Pharmaceutical Services Branch guidance, the operational expectations for the narcotic substance drug register are:

  • Every transaction must be recorded: All narcotic substances obtained, supplied, administered, transferred, or destroyed must be entered. PBS Doctor's Bag receipts must be recorded as soon as practicable after receipt.
  • Contemporaneous entries: Based on current guidance, register entries are expected to be made contemporaneously with the transaction.
  • Running balance: Each narcotic substance item must show a true balance after every transaction.
  • Retention period: Based on current Pharmaceutical Services Branch guidance, the standard retention period for the narcotic substance drug register in Tasmania is 2 years from the date of the last entry. Verify the applicable retention period against current guidance before disposing of any S8-related document.

DORA: Tasmania's Real-Time Prescription Monitoring System

DORA (Drugs and Poisons Information System Online Remote Access) is Tasmania's real-time prescription monitoring system. Tasmania was the first Australian state to implement real-time prescription monitoring; DORA has been operational since 2009. From 2011, DORA enabled clinicians to view clinical information and dispensing data about Schedule 8 drugs, and current and past authorities issued for the prescribing of Schedule 8 drugs to specific patients.

Key DORA features:

  • Confirms whether or not the patient has been declared drug-dependent or a drug seeker (as defined by the Poisons Act 1971).
  • Confirms whether the patient has ever been treated in Tasmania for an opioid substance use disorder.
  • Surfaces current and past s59E authorities for the patient.

Use of DORA by clinicians is currently not mandatory in Tasmania, in contrast to Victoria's SafeScript (mandatory check from 1 April 2020) and Queensland's QScript (mandatory check from 28 October 2021). Verify the current mandatory-check status directly against current Pharmaceutical Services Branch guidance, as this position has been the subject of ongoing review.

Interstate Prescribing Changes Commencing 16 February 2026

Significant changes to the Poisons Act 1971 and the Poisons Regulations 2018 commenced on 16 February 2026. Based on current Tasmanian Department of Health guidance:

  • From 16 February 2026, pharmacists in Tasmania may dispense a valid interstate prescription for almost any medicine that has been written by an AHPRA-registered health professional. This includes narcotic substances (S8s), declared restricted substances (S4Ds), psychostimulants, opioids, medicinal cannabis, and benzodiazepines.
  • The location of the prescriber (within Australia) no longer restricts the dispensing of certain medicines in Tasmania.
  • Travellers to Tasmania from interstate who bring valid prescriptions can have these dispensed by local Tasmanian pharmacists.

Tasmanian Patients and Interstate Prescribers

Critically, based on current Tasmanian Department of Health guidance, where an interstate prescriber writes a prescription for a Tasmanian patient, the prescriber is required to comply with Tasmanian requirements. This includes any obligation to seek a section 59E authority from the Secretary of the Tasmanian Department of Health to make available S8 medicines, in order to ensure the prescriber is not committing an offence under section 59C of the Poisons Act 1971.

Practitioners working across state borders should be aware that the 2026 changes do not relieve interstate prescribers of Tasmanian regulatory obligations when prescribing for Tasmanian patients. Confirm where the patient intends to have their medicine dispensed where there is doubt.

Self-Prescribing

Based on current Tasmanian Department of Health guidance and the framework of the Poisons Act 1971, self-prescribing of narcotic substances is not permitted. Verify the current state of the rule directly against the Poisons Act and Pharmaceutical Services Branch guidance.

Loss or Theft of Narcotic Substances

If any narcotic substance in your Doctor's Bag is lost, stolen, or otherwise unaccounted for, you must notify the Tasmanian Department of Health Pharmaceutical Services Branch. Based on current guidance:

  • Notify Pharmaceutical Services Branch by phone or email at the earliest opportunity.
  • Submit the prescribed loss/theft notification form.
  • If theft is suspected, notify Tasmania Police as well.

The discrepancy must be recorded in the drug register, including the date the discrepancy was identified and the notification reference. Failing to report a loss or theft of a narcotic substance is itself an offence under the Poisons Act 1971. Loss of the Prescriber Bag Supply Order Book (PB052) requires a separate report to Services Australia for HPOS replacement.

Destruction of Unwanted or Expired Narcotic Substances

Based on current Tasmanian Department of Health Pharmaceutical Services Branch guidance:

  • Render unusable and unidentifiable: Before disposal, the narcotic substance should be physically destroyed to render it unusable, unrecoverable, and unidentifiable.
  • Witnessed destruction: Destruction is to be carried out by an authorised person and witnessed by another authorised person.
  • Drug register entry: The destruction must be recorded in the narcotic substance register with full details, including date, drug name and strength, quantity destroyed, reason for destruction, and the names and signatures of the destroying practitioner and witness.
  • Approved disposal pathway: Once rendered unusable, the destroyed material must be disposed of via an approved pathway. Verify the current approved pathways and any operational considerations for Tasmania directly against current Pharmaceutical Services Branch guidance.

Order your PBS Doctor's Bag through DocPouch

Common Compliance Pitfalls for Tasmanian Doctor's Bag Holders

  1. "I prescribed long-term S8 opioids without an authority because the patient is not drug-dependent." Verify the current section 59E authority requirements carefully against Pharmaceutical Services Branch guidance. Section 59E captures multiple categories beyond drug-dependent patients, including opioids in long-term treatment.
  2. "I'll prescribe interstate; my patient can fill it in Tasmania." The 16 February 2026 changes allow interstate prescriptions to be dispensed in Tasmania, but the interstate prescriber is still required to comply with Tasmanian section 59E obligations when prescribing for a Tasmanian patient. Section 59C creates an offence for making an S8 available without proper authority.
  3. "DORA is mandatory like SafeScript." Based on current guidance, use of DORA by clinicians is not currently mandatory in Tasmania, in contrast to Victoria's SafeScript and Queensland's QScript. Verify the current position before relying on this.
  4. "I left the Doctor's Bag in my locked car for 30 minutes." The S8 contents must be stored in a compliant locked storage facility when not in the practitioner's personal possession. A locked vehicle is unlikely to satisfy this requirement.
  5. "I'll catch up the drug register at end of week." Based on current Pharmaceutical Services Branch guidance, register entries are expected to be made contemporaneously with the transaction.
  6. "I prescribed S8 medicinal cannabis without a section 59E authority." Authorisation under section 59E is required prior to issuing a prescription for an S8 medicinal cannabis product to a patient.
  7. "I prescribed an S8 to myself." Self-prescribing of narcotic substances is not permitted under current Tasmanian guidance.

How DocPouch Supports Tasmanian Doctor's Bag Compliance

DocPouch is fulfilled through Priceline Pharmacy Sunshine Marketplace, a Section 90 PBS-approved community pharmacy located at Shop MM002, 80 Harvester Road, Sunshine VIC 3020. DocPouch handles the Commonwealth (PBS) side of the workflow: AHPRA-verified prescriber accounts, signed PB052 form upload, dispatch as the approved supplier, and record retention for the supplier-side claim. The state-side compliance obligations (storage, drug register, DORA use, section 59E authority where required, transport, destruction, and loss notification) remain with the prescriber as a matter of Tasmanian law.

For the broader ordering workflow, see our companion guides on how to get your Prescriber Bag Supply Order Book through HPOS and how to order your PBS Doctor's Bag online in Australia. For the items themselves, see the A-Z PBS Doctor's Bag medication list.

Frequently Asked Questions: Tasmanian Doctor's Bag Compliance

Does the PBS Doctor's Bag scheme exempt me from Tasmanian Poisons Act rules?

No. The PBS scheme is a Commonwealth funding and access mechanism. Storage, recordkeeping, transport, prescribing, and destruction of narcotic substances are governed by Tasmanian state law under the Poisons Act 1971 and Poisons Regulations 2018, plus current Pharmaceutical Services Branch guidance.

What is a "narcotic substance" in Tasmanian law?

Section 3(1) of the Poisons Act 1971 defines a narcotic substance as a substance specified in Schedule 8 of the Poisons List. For practical purposes, narcotic substances correspond to Schedule 8 substances under the Commonwealth Poisons Standard.

When do I need a section 59E authority?

Section 59E of the Poisons Act sets out the authority regime for prescribing S8 medicines including strong opioids, psychostimulants, S8 benzodiazepines, and S8 medicinal cannabis. Authority is required prior to issuing a prescription in defined circumstances. Verify the current scope of the authority requirement directly against Pharmaceutical Services Branch guidance.

Is DORA use mandatory before I prescribe?

Based on current guidance, use of DORA by clinicians is not currently mandatory in Tasmania, in contrast to Victoria's SafeScript and Queensland's QScript. Verify the current position directly against Pharmaceutical Services Branch guidance.

What changed on 16 February 2026 for interstate prescribing?

From 16 February 2026, Tasmanian pharmacists may dispense valid interstate prescriptions for almost any medicine, including narcotic substances and declared restricted substances. However, where an interstate prescriber writes a prescription for a Tasmanian patient, the prescriber is still required to comply with Tasmanian section 59E obligations. The change opens the dispensing pathway but does not relieve interstate prescribers of Tasmanian regulatory obligations.

How long do I keep the narcotic substance drug register in Tasmania?

Based on current Pharmaceutical Services Branch guidance, the standard retention period for the narcotic substance drug register in Tasmania is 2 years from the date of the last entry.

Where do I report a stolen or lost ampoule from my Doctor's Bag?

Notify the Tasmanian Department of Health Pharmaceutical Services Branch by phone or email at the earliest opportunity, and submit the prescribed loss/theft notification form. If theft is suspected, also notify Tasmania Police. Loss of the Prescriber Bag Supply Order Book requires a separate report to Services Australia for HPOS replacement.

Can I prescribe a narcotic substance for myself in Tasmania?

No. Based on current Tasmanian Department of Health guidance, self-prescribing of narcotic substances is not permitted. Verify the current state of the rule directly against the Poisons Act and Pharmaceutical Services Branch guidance.

Key Takeaways for Tasmanian Prescribers

  • Two bodies of law apply at once: PBS (Commonwealth) governs supply and funding; Tasmanian Poisons Act 1971 and Poisons Regulations 2018 govern everything else.
  • Tasmania uses unique terminology: "narcotic substance" (= S8), "declared restricted substance" / "S4D" (= some S4s), "midwifery narcotic substance" / "midwifery restricted substance".
  • Section 59E sets the authority regime for prescribing S8 medicines; section 59B governs notification of drug seeking; section 59C creates the offence of making an S8 available without proper authority.
  • Sections 25A and 25B authorise Minister/Secretary-issued authorisations for nurses, midwives, and nurse practitioners.
  • Section 59E authorisation is required prior to issuing a prescription for S8 medicinal cannabis.
  • A formal review process exists for s59E authority decisions, implemented after Tasmanian Ombudsman review.
  • Storage: based on current Pharmaceutical Services Branch guidance, narcotic substances must be in a securely locked storage facility; the Doctor's Bag must remain in personal possession during use.
  • Drug register: contemporaneous entries; running balance; based on current guidance, 2-year retention from last entry.
  • DORA has been operational since 2009; based on current guidance, DORA use by clinicians is not currently mandatory.
  • From 16 February 2026, Tasmanian pharmacists may dispense valid interstate prescriptions; interstate prescribers writing for Tasmanian patients are still required to comply with section 59E obligations.
  • Self-prescribing of narcotic substances is not permitted under current guidance.
  • Loss/theft must be reported to Pharmaceutical Services Branch; Tasmania Police if theft is suspected.

Order your PBS Doctor's Bag through DocPouch.

Related Guides

Disclaimer. This article is published by Doc Pouch Pty Ltd (ABN 28 695 916 306), trading as DocPouch, for general informational purposes only. It is directed to AHPRA-registered Australian healthcare professionals practising in Tasmania and does not constitute legal, regulatory, clinical, financial, or professional advice. Reading this article does not create a solicitor-client, advisor-client, or any other professional relationship between the reader and DocPouch, Doc Pouch Pty Ltd, Priceline Pharmacy Sunshine Marketplace, or any of their officers, employees, contractors, or agents. References have been compiled from the Poisons Act 1971 (Tas), the Poisons Regulations 2018 (Tas), and current Tasmanian Department of Health Pharmaceutical Services Branch guidance current at 3 May 2026. Legislation, the Regulations, and Departmental guidance change without notice; always verify the current state of Tasmanian law before relying on this article. State requirements differ materially from those in NSW, Victoria, Queensland, Western Australia, South Australia, the Australian Capital Territory, and the Northern Territory. DocPouch's commercial role is limited to the supply of PBS Prescriber Bag items through Priceline Pharmacy Sunshine Marketplace (a Section 90 PBS-approved community pharmacy); state-side compliance is the sole responsibility of the prescriber. To the maximum extent permitted by law, DocPouch and Doc Pouch Pty Ltd exclude all liability arising from any reliance placed on this article.